Table:
begin	end	state
1	22	cytoplasmic
23	50	transmembrane
51	62	non-cytoplasmic
63	83	transmembrane
84	89	cytoplasmic
90	110	transmembrane
111	115	non-cytoplasmic
116	137	transmembrane
138	149	cytoplasmic
150	169	transmembrane
170	178	non-cytoplasmic
179	198	transmembrane
199	257	cytoplasmic
258	281	transmembrane
282	296	non-cytoplasmic
297	318	transmembrane
319	328	cytoplasmic
329	348	transmembrane
349	359	non-cytoplasmic
360	384	transmembrane
385	403	cytoplasmic
404	422	transmembrane
423	427	non-cytoplasmic
428	446	transmembrane
447	472	cytoplasmic

Input:
>BWI76_RS23425
MTSISHDSTTMPRTQRDTRRMNQFVSVAAAVAGLLFGLDIGVIAGALPFITDHFVLSSRL
QEWVVSSMMLGAAIGALFNGWLSFRLGRKYSLMVGAVLFVAGSVGSAFAGSVEMLLAARI
VLGVAVGIASYTAPLYLSEMASENVRGKMISMYQLMVTLGIVMAFLSDTAFSYSGNWRAM
LGVLALPALVLIILVIFLPNSPRWLAEKGRHVEAEEVLRMLRDTSEKARDELNEIRESLK
LKQGGWALFKVNRNVRRAVFLGMLLQAMQQFTGMNIIMYYAPRIFKMAGFTTTEQQMVAT
LVVGLTFMFATFIAVFTVDKAGRKPALKIGFSVMAIGTLVLGYCLMQFDNGTASSGLSWL
SVGMTMMCIAGYAMSAAPVVWILCSEIQPLKCRDFGITCSTTTNWVSNMIIGATFLTLLD
AIGAAGTFWLYTALNVAFIGVTFWLIPETKNVTLEHIERKLMSGEKLRNIGN

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server